Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19—A Preliminary Study

Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19—A Preliminary Study

Severe coronavirus disease 2019 (COVID-19) is associated with hyperinflammation leading to organ injury, including respiratory failure. Galectin-3 was implicated in innate immunological response to infections and in chronic fibrosis. The aim of our preliminary study was the assessment of the diagnos...

Full description

Bibliographic Details
Main Authors:	Beata Kuśnierz-Cabala, Barbara Maziarz, Paulina Dumnicka, Marcin Dembiński, Maria Kapusta, Monika Bociąga-Jasik, Marek Winiarski, Aleksander Garlicki, Tomasz Grodzicki, Michał Kukla
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Biomolecules
Subjects:	galectin-3 soluble fms-like tyrosine kinase-1 SARS-CoV-2 COVID-19 inflammation
Online Access:	https://www.mdpi.com/2218-273X/11/8/1136

Similar Items

The Role of the Aryl Hydrocarbon Receptor in Vascular Factors Related to Preeclampsia in a Smoking Mouse Model
by: Ho-Yeon Kim, et al.
Published: (2024-01-01)

Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study
by: Ahmed M. Abbas, et al.
Published: (2018-07-01)

Distinct phenotypes in the preeclamptic-like mouse model induced by adenovirus carrying sFlt1 and recombinant sFlt1 protein
by: Yingying Wei, et al.
Published: (2024-12-01)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
by: Jiawu Zhao, et al.
Published: (2024-01-01)

Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia
by: Ping Tang, et al.
Published: (2017-01-01)

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study
by: Jinsong Gao, et al.
Published: (2021-08-01)

Soluble fms-like tyrosine kinase-1 and vascular endothelial growth factor: Novel markers for unexplained early recurrent pregnancy loss
by: Mahmoud Fathy Hassan
Published: (2014-03-01)

Relation between FMS-like tyrosine kinase 3 factor and hematological parameter in acute lymphoblastic leukemia patients by flow cytometry
by: Zainab Samir Al-Ali, et al.
Published: (2022-01-01)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
by: Vorapong Phupong, et al.
Published: (2020-04-01)

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)
by: Alice Hurrell, et al.
Published: (2022-09-01)

The role of proangiogenic cytokines in predicting sepsis in febrile neutropenic children with cancer
by: Selma Çakmakcı, et al.
Published: (2024-02-01)

Role of soluble fms-like tyrosine kinase-1/placental growth factor ratio along with uterine artery Doppler for the prediction of pre-eclampsia – A case–control study
by: Sathya Jagdish, et al.
Published: (2024-05-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
by: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Published: (2023-05-01)

No association between early antiretroviral therapy during pregnancy and plasma levels of angiogenic factors: a cohort study
by: Ameyo Djeha, et al.
Published: (2019-12-01)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
by: Riad El Fakih, et al.
Published: (2018-01-01)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
by: Xinwen Chang, et al.
Published: (2023-08-01)

Angiogenic Biomarker Placental Growth Factor (PLGF) in the Prediction and Diagnosis of Placental Dysfunction in Pre-eclampsia: A Cohort Study
by: Mandeep Kaur, et al.
Published: (2023-06-01)

Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course
by: Michał Kukla, et al.
Published: (2021-09-01)

Effect of galectin‐1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
by: Jiajun Wang, et al.
Published: (2024-04-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
by: Alaa Raeed, et al.
Published: (2024-04-01)

Diagnostic value of sFlt‐1/PlGF‐1 ratio and plasma PROK1 for adverse pregnancy outcomes in women with hypertensive disease of pregnancy
by: Ping Lv, et al.
Published: (2024-12-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019-07-01)

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
by: Yuanwei Shi, et al.
Published: (2022-05-01)

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
by: Daniel Compagno, et al.
Published: (2020-05-01)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01)

Is the sFlt-1/PlGF ratio efficient in predicting adverse neonatal outcomes in small-for-gestational-age newborns? A prospective observational multicenter cohort study
by: Katarzyna Kosińska-Kaczyńska, et al.
Published: (2024-06-01)

The Importance of Inflammatory and Angiogenic Markers in the Evaluation of Early Cardiovascular Disease Risk in Women with Hypertensive Disorders of Pregnancy
by: Tatjana Maselienė, et al.
Published: (2023-09-01)

THE ROLE OF THE PIGF/SFLT-1 RELATIONSHIP IN PREDICTING PREECLAMPSIA (LITERATURE REVIEW)
by: Irina Venzkovskaya, et al.
Published: (2019-04-01)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
by: Nesreen Nasser, et al.
Published: (2020-12-01)

Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML
by: Maya Graham Pedersen, et al.
Published: (2022-09-01)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
by: Julia Nowowiejska, et al.
Published: (2023-09-01)

Added value of mean blood pressure and placental growth factor in the early detection of pre-eclampsia among gabonese women
by: Elisabeth Lendoye, et al.
Published: (2024-01-01)

Maternal serum soluble fms-like tyrosine kinase-1–to–placental growth factor ratio distinguishes growth-restricted from non–growth-restricted small-for-gestational-age fetusesAJOG Global Reports at a Glance
by: Prithi Rajiv, MD, et al.
Published: (2024-02-01)

Correlation between N‐terminal pro‐atrial natriuretic peptide, corin, and target organ damage in hypertensive disorders of pregnancy
by: Wei Zhang, et al.
Published: (2022-05-01)

sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women With SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy
by: Jose Antonio Hernandez-Pacheco, et al.
Published: (2022-05-01)

Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-03-01)

The Role of Soluble fms-Like Tyrosine Kinase-1 Markers and Vascular Endothelial Growth Factor in Comparison with Color Doppler Sonography for Detecting Plasenta Accreta
by: Elhan Naghshineh, et al.
Published: (2019-05-01)